As of 2026-06-25, the Intrinsic Value of Amgen Inc (AMGN) is 357.23 USD. This Amgen valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 351.43 USD, the upside of Amgen Inc is 1.70%.
The range of the Intrinsic Value is 222.46 - 748.80 USD
Based on its market price of 351.43 USD and our intrinsic valuation, Amgen Inc (AMGN) is undervalued by 1.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 222.46 - 748.80 | 357.23 | 1.7% |
| DCF (Growth 10y) | 287.80 - 872.67 | 438.60 | 24.8% |
| DCF (EBITDA 5y) | 186.19 - 264.74 | 216.44 | -38.4% |
| DCF (EBITDA 10y) | 253.10 - 364.91 | 297.67 | -15.3% |
| Fair Value | 127.90 - 127.90 | 127.90 | -63.60% |
| P/E | 252.05 - 418.75 | 320.55 | -8.8% |
| EV/EBITDA | 162.91 - 230.35 | 188.19 | -46.5% |
| EPV | 191.50 - 282.67 | 237.09 | -32.5% |
| DDM - Stable | 139.87 - 494.65 | 317.26 | -9.7% |
| DDM - Multi | 200.40 - 561.33 | 296.61 | -15.6% |
| Market Cap (mil) | 189,670.28 |
| Beta | 0.26 |
| Outstanding shares (mil) | 539.71 |
| Enterprise Value (mil) | 234,955.28 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.93% |
| Cost of Debt | 5.00% |
| WACC | 7.11% |